IsoPlexis Investor Relations Material

IsoPlexis Corporation is a life sciences company that provides solutions for the development of curative medicines and personalized therapeutics for orphan diseases. The company's system enables faster and more accurate drug discovery by identifying compounds that will pass preclinical testing, reducing clinical trials costs and speeding to market. With a platform approach to drug discovery, IsoPlexis has built a robust discovery team with an experienced leadership team and institutional knowledge.